Lindbrook Capital, LLC Tg Therapeutics, Inc. Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 826 shares of TGTX stock, worth $27,728. This represents 0.0% of its overall portfolio holdings.

Number of Shares

826

Previous 754 9.55%

Holding current value

$27,728

Previous $13,000 46.15%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$17.21 - $25.28 $1,239 - $1,820	72 Added 9.55%	826 $19,000
Q2 2024 Jul 31, 2024	BUY	$13.32 - $19.19 $559 - $805	42 Added 5.9%	754 $13,000
Q1 2024 Apr 25, 2024	SELL	$13.02 - $21.3 $911 - $1,491	-70 Reduced 8.95%	712 $10,000
Q4 2023 Jan 31, 2024	BUY	$6.68 - $18.81 $2,625 - $7,392	393 Added 101.03%	782 $13,000
Q3 2023 Oct 25, 2023	BUY	$8.36 - $26.5 $367 - $1,166	44 Added 12.75%	389 $3,000
Q2 2023 Jul 28, 2023	BUY	$15.48 - $35.0 $232 - $525	15 Added 4.55%	345 $8,000
Q1 2023 Apr 26, 2023	BUY	$10.23 - $19.34 $276 - $522	27 Added 8.91%	330 $4,000
Q4 2022 Jan 24, 2023	BUY	$5.01 - $11.83 $1,017 - $2,401	203 Added 203.0%	303 $0
Q3 2022 Nov 10, 2022	SELL	$4.57 - $8.4 $1,096 - $2,016	-240 Reduced 70.59%	100 $1,000
Q2 2022 Aug 01, 2022	SELL	$3.74 - $10.66 $213 - $607	-57 Reduced 14.36%	340 $1,000
Q1 2022 Apr 21, 2022	SELL	$7.81 - $20.45 $5,631 - $14,744	-721 Reduced 64.49%	397 $4,000
Q4 2021 Jan 18, 2022	SELL	$15.2 - $35.51 $21,006 - $49,074	-1,382 Reduced 55.28%	1,118 $21,000
Q3 2021 Nov 05, 2021	SELL	$21.78 - $40.45 $10,890 - $20,225	-500 Reduced 16.67%	2,500 $83,000
Q2 2021 Jul 27, 2021	BUY	$32.5 - $48.96 $13,000 - $19,584	400 Added 15.38%	3,000 $116,000
Q1 2021 Apr 28, 2021	BUY	$41.61 - $54.3 $45,771 - $59,730	1,100 Added 73.33%	2,600 $125,000
Q4 2020 Jan 27, 2021	BUY	$25.27 - $54.9 $12,635 - $27,450	500 Added 50.0%	1,500 $78,000
Q2 2020 Jul 27, 2020	BUY	$8.9 - $21.84 $8,900 - $21,840	1,000 New	1,000 $19,000
Q2 2019 Jul 24, 2019	SELL	$6.27 - $8.65 $6,270 - $8,650	-1,000 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$3.44 - $5.76 $3,440 - $5,760	1,000 New	1,000 $4,000

Others Institutions Holding TGTX

# of Institutions

339

Shares Held

88.5M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.88B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Tg Therapeutics, Inc. Transaction History